Advertising Alert: FDA Offers Draft Guidance Concerning the Presentation and Correction of Information on Internet/Social Media Platforms Regarding Prescription Drugs and Medical Devices
Diversity & Community Services Mosaics Newsletter: Summer 2014
Kramer Levin Naftalis & Frankel LLP has long been known for handling complex white collar cases, from investigation through trial and appeal. Our White Collar Defense Group draws on a diverse group of lawyers with the experience and judgment to successfully guide our clients through the complicated and sensitive issues presented by criminal and regulatory matters.
The group is co-chaired by Gary P. Naftalis and Barry H. Berke, and includes former senior federal prosecutors, trial lawyers from the Federal Defender’s Office, counsel for Congressional committees and fellows of the American College of Trial Lawyers. We try cases, and our courtroom experience attracts many clients to our group. The fact that our adversaries know we are ready and able to take a case to trial provides numerous advantages, whether a matter is resolved well before any charges are filed or proceeds all the way to verdict.
Our cases involve every substantive aspect of white collar criminal and regulatory work affecting U.S. and foreign business entities and individuals, including:
We regularly represent corporations and their officers, directors and employees, as well as public officials, in U.S. Attorney, Department of Justice, SEC, FINRA, state attorney general and congressional inquiries. We frequently handle matters involving parallel civil class actions and criminal, SEC or other regulatory proceedings.
We represent numerous companies and individuals in government inquiries and related litigation arising out of the recent financial crisis, and for many years have defended corporations and senior corporate officials in a wide range of government investigations alleging “earnings management” and other securities and accounting frauds.
We have significant representations in governmental inquiries relating to Ernst & Young, Bear Stearns, UBS, Enron, Global Crossing, WorldCom, Tyco, Galleon Group, Rite Aid, Cendant, Bristol-Myers Squibb, ImClone, Oxford Health Plans and Micro Warehouse, among other issuers.
In addition, we have extensive experience in counseling clients concerning preventive measures, such as corporate compliance programs; we frequently conduct independent internal investigations of corporate conduct; and we have acted on behalf of audit committees and other special committees investigating accounting fraud and other alleged wrongdoing. Most recently, we have been involved in special investigations or independent committees relating to Moody's, Cardinal Health, AIG and WebMD.